These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1968740

  • 21. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A, Sobbrio GA, D'Arrigo F, Barillari M, Curasì MP, Egitto M, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [Abstract] [Full Text] [Related]

  • 22. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S, Gamez R, Mas R, Goicochea E.
    Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
    [Abstract] [Full Text] [Related]

  • 23. Effect of prazosin and propranolol on lipoproteins of hypertensive patients.
    Hurt E, Velasco M, Silva H, Camejo G.
    Biomed Biochim Acta; 1987; 46(1):111-8. PubMed ID: 3107546
    [Abstract] [Full Text] [Related]

  • 24. Regulation of liver lipase. II. Involvement of the alpha 1-receptor.
    Schoonderwoerd K, Hülsmann WC, Jansen H.
    Biochim Biophys Acta; 1984 Oct 04; 795(3):481-6. PubMed ID: 6148107
    [Abstract] [Full Text] [Related]

  • 25. Lipid profile improvement following celiprolol.
    Herrmann JM, von Heyman F, Freischütz G.
    J Int Med Res; 1988 Oct 04; 16 Suppl 1():39A-46A. PubMed ID: 2906016
    [Abstract] [Full Text] [Related]

  • 26. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
    Pruss TP, Khandwala A, Wolf PS, Grebow P, Wong L.
    J Cardiovasc Pharmacol; 1986 Oct 04; 8 Suppl 4():S29-32. PubMed ID: 2427849
    [Abstract] [Full Text] [Related]

  • 27. Effects of different beta-blockers on lipid metabolism in chronic therapy of hypertension.
    Fogari R, Zoppi A, Pasotti C, Poletti L, Tettamanti F, Maiwald C.
    Int J Clin Pharmacol Ther Toxicol; 1988 Dec 04; 26(12):597-604. PubMed ID: 2905341
    [Abstract] [Full Text] [Related]

  • 28. The effect of cyclosporine and methylprednisolone on plasma lipoprotein levels in rats.
    Espino A, Lopez-Miranda J, Blanco-Cerrada J, Zambrana JL, Aumente MA, Paniagua JA, Blanco-Molina A, Jimenez-Pereperez JA, Rodriguez M, Pérez-Jiméz F.
    J Lab Clin Med; 1995 Feb 04; 125(2):222-7. PubMed ID: 7844470
    [Abstract] [Full Text] [Related]

  • 29. The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients.
    Yamamoto T, Kitazawa Y, Noma A, Maeda S, Kato A, Ando Y, Ido T, Inazumi K, Hayakawa T, Goto Y, Ichien M.
    J Glaucoma; 1996 Aug 04; 5(4):252-7. PubMed ID: 8795770
    [Abstract] [Full Text] [Related]

  • 30. Effects of doxazosin and propranolol administration on lipoprotein lipases in cholesterol-fed rats.
    Jansen H, Baggen RG.
    J Cardiovasc Pharmacol; 1987 Aug 04; 10 Suppl 9():S16-20. PubMed ID: 2447435
    [Abstract] [Full Text] [Related]

  • 31. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
    Pool JL, Lenz ML, Taylor AA.
    J Hum Hypertens; 1990 Oct 04; 4 Suppl 3():23-33. PubMed ID: 1979819
    [Abstract] [Full Text] [Related]

  • 32. beta-blockade, atrial natriuretic peptide and exercise.
    Kantola I, Tarssanen L, Scheinin M, Ruskoaho H, Viinamäki O, Kaila T.
    Int J Clin Pharmacol Ther; 1996 Jan 04; 34(1):12-6. PubMed ID: 8688991
    [Abstract] [Full Text] [Related]

  • 33. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J, Saku K, Ideishi M, Arakawa K, Kato Y, Kuwano E, So T.
    Clin Ther; 1989 Jan 04; 11(2):219-24. PubMed ID: 2736568
    [Abstract] [Full Text] [Related]

  • 34. Effects of diltiazem hydrochloride on serum lipids: comparison with beta-blockers.
    Wada S, Nakayama M, Masaki K.
    Clin Ther; 1982 Jan 04; 5(2):163-73. PubMed ID: 6130841
    [Abstract] [Full Text] [Related]

  • 35. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep 04; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 36. Preventive effect of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol-induced myocardial infarction in rats.
    Stanely Mainzen Prince P, Karthick M.
    J Biochem Mol Toxicol; 2007 Sep 04; 21(1):1-6. PubMed ID: 17366541
    [Abstract] [Full Text] [Related]

  • 37. Blood lipids and antihypertensive drugs. The Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Pharmacol; 1983 Sep 04; 14 Suppl 2():217-20. PubMed ID: 6632918
    [Abstract] [Full Text] [Related]

  • 38. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
    Sirtori CR, Johnson B, Vaccarino V, Montanari G, Cremoncini M, Gianfranceschi G, Sirtori M, Dujovne CA.
    Clin Pharmacol Ther; 1989 Jun 04; 45(6):617-26. PubMed ID: 2567218
    [Abstract] [Full Text] [Related]

  • 39. The effects of cardioselective vasodilating beta-blockers on lipids.
    Hunninghake DB.
    Am Heart J; 1991 Mar 04; 121(3 Pt 2):1029-32. PubMed ID: 1671728
    [Abstract] [Full Text] [Related]

  • 40. Effects of beta-blockers on the concentration and oxidizability of plasma lipids.
    Dimmitt SB, Williams PD, Croft KD, Beilin LJ.
    Clin Sci (Lond); 1998 Jun 04; 94(6):573-8. PubMed ID: 9854453
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.